ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ENTX Entera Bio Ltd

2.09
0.09 (4.50%)
取引時間後
最終更新日: 05:30:00
15分遅延
名称 銘柄コード 市場 種別
Entera Bio Ltd ENTX NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.09 4.50% 2.09 05:30:00
始値 安値 高値 終値 前日終値
2.05 1.93 2.12 2.09 2.00
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/4/0821:30GLOBEEntera Bio Announces Publication of Oral PTH(1-34) Peptide..
2024/3/2621:30GLOBEEntera Bio Announces Key Regulatory Milestone for Oral..
2024/3/2021:00GLOBEEntera Bio Announces Robust Pharmacokinetic Data for..
2024/3/0906:25EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0906:12EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0906:10EDGAR2Form 8-K - Current report
2024/3/0906:05GLOBEEntera Bio Announces Full Year 2023 Financial Results and..
2024/3/0422:30EDGAR2Form 8-K - Current report
2024/3/0422:30GLOBEEntera Bio Regains Compliance with Nasdaq Minimum Bid Price..
2024/2/1607:10EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/2/1514:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/2/1420:05EDGAR2Form S-3/A - Registration statement under Securities Act of..
2024/2/0306:19EDGAR2Form 8-K - Current report
2024/2/0306:17EDGAR2Form S-3 - Registration statement under Securities Act of..
2024/1/3022:30GLOBEEntera Bio to Present at the Oppenheimer 34th Annual..
2024/1/1622:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/1208:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0408:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0406:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0322:00EDGAR2Form 8-K - Current report
2023/12/2722:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/12/2622:00EDGAR2Form 8-K - Current report
2023/12/2622:00GLOBEEntera Bio Announces Closing of Private Placement - Extends..
2023/11/2922:30GLOBEInterim Results from Ongoing Clinical Study Confirm EB613..
2023/11/1421:30GLOBEEntera Bio Reports Q3 2023 Financial Results, Highlights..
2023/11/1004:30GLOBEEntera Bio Reports Key Milestone Relating to Oral PTH (1-34)..
2023/10/1621:00GLOBEEntera Bio Reports Rapid Pharmacodynamic (PD) Response and..
2023/9/1506:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1506:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/9/1405:05EDGAR2Form 8-K - Current report
2023/9/1221:30GLOBEEntera Bio Announces Collaboration with OPKO Biologics to..
2023/9/0521:00GLOBEEntera Bio to Participate in Upcoming Investor Conferences
2023/8/2421:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/2421:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/2222:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/1621:30GLOBEEntera Bio to Present Two Abstracts on its First-in-Class,..
2023/8/1605:10EDGAR2Form DEF 14A - Other definitive proxy statements
2023/8/1205:19EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/1205:16EDGAR2Form 8-K - Current report
2023/8/1205:05GLOBEEntera Bio Announces Q2 2023 Financial Results and Corporate..
2023/7/0105:06EDGAR2Form 8-K - Current report
2023/6/0720:30GLOBEEntera Bio Adds Sanofi Commercial Leader, Haya Taitel to its..
2023/5/0605:05GLOBEEntera Bio Announces Q1 2023 Financial Results and Corporate..
2023/5/0322:34GLOBEEntera’s Oral Delivery of GLP-2 Pre-Clinical Data to be..

最近閲覧した銘柄

Delayed Upgrade Clock